Less than a year after debuting its Wirion embolic protection system, Cardiovascular Systems is recalling all of the devices manufactured and distributed between January and November 2021. The Wirion ...
RALEIGH, North Carolina, April 27, 2017 /PRNewswire/ -- Contego Medical, LLC announced today that it has received CE Marking of its Vanguard IEP™ Peripheral Balloon Angioplasty System with Integrated ...
CAMPBELL, Calif., June 30, 2025 /PRNewswire/ -- Verge Medical, a privately held medical technology company focused on advancing physician-driven solutions to address persistent gaps in vascular care, ...
(MENAFN- GlobeNewsWire - Nasdaq) The Embolic Protection Devices Market Growth is Fueled by Rising Incidence of Cardiovascular Diseases and Neurovascular Interventions. Austin, Nov. 13, 2025 (GLOBE ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/x79h5q/embolic) has announced the addition of the "Embolic Protection ...
DUBLIN, April 18, 2023 /PRNewswire/ -- The "Embolic Protection Device Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been ...
A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...
Medtronic reported that its new thrombectomy system, aimed at removing blood clots from the arms and legs, has begun its ...
CHICAGO, IL—Cerebral embolic protection devices are infrequently used during transcatheter aortic valve implantation procedures in the United States, and new data suggest their use does not appear to ...
A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...
Please provide your email address to receive an email when new articles are posted on . Routine cerebral embolic protection did not reduce stroke in patients undergoing transcatheter aortic valve ...